There are 2934 resources available
4511 - POLO: Health-related quality of life (HRQoL) of olaparib maintenance treatment versus placebo in patients with a germline BRCA mutation and metastatic pancreatic cancer (mPC)
Presenter: Pascal Hammel
Session: Poster Discussion – Gastrointestinal tumours, non-colorectal
Resources:
Abstract
4638 - Health-Related Quality of Life (HRQoL) Impact of Pembrolizumab (P) Versus Chemotherapy (C) as First-Line (1L) Treatment in PD-L1–Positive Advanced Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma
Presenter: Eric Van Cutsem
Session: Poster Discussion – Gastrointestinal tumours, non-colorectal
Resources:
Abstract
5708 - Chemotherapy for Frail and Elderly Patients (pts) with Advanced Gastroesophageal Cancer (aGOAC): Quality of Life (QoL) results from the GO2 Phase III Trial
Presenter: Peter Hall
Session: Poster Discussion – Gastrointestinal tumours, non-colorectal
Resources:
Abstract
6574 - Randomized, open-label, perioperative phase II study evaluating nivolumab alone versus nivolumab plus ipilimumab in patients with resectable HCC
Presenter: Ahmed Kaseb
Session: Poster Discussion – Gastrointestinal tumours, non-colorectal
Resources:
Abstract
Poster Discussion – Gastrointestinal tumours, non-colorectal - Invited Discussant 673PD and 674PD
Presenter: Hanneke van Laarhoven
Session: Poster Discussion – Gastrointestinal tumours, non-colorectal
Resources:
Slides
Webcast
Poster Discussion – Gastrointestinal tumours, non-colorectal - Invited Discussant LBA45, LBA46, 675PD and 676PD
Presenter: Florian Lordick
Session: Poster Discussion – Gastrointestinal tumours, non-colorectal
Resources:
Slides
Webcast
Poster Discussion – Gastrointestinal tumours, non-colorectal - Invited Discussant 677PD, 678PD, 679PD and 680PD
Presenter: Russell Petty
Session: Poster Discussion – Gastrointestinal tumours, non-colorectal
Resources:
Slides
Webcast
Poster Discussion – Gastrointestinal tumours, non-colorectal - Invited Discussant 681PD and LBA47
Presenter: Ana Raimundo
Session: Poster Discussion – Gastrointestinal tumours, non-colorectal
Resources:
Slides
Webcast
5576 - Genomic characteristics and predicted ancestry of NTRK1/2/3 and ROS1 fusion-positive tumors from >165,000 pan-solid tumors
Presenter: Timothy R Wilson
Session: Poster Discussion – Developmental therapeutics
Resources:
Abstract
4536 - Safety and preliminary clinical activity of repotrectinib in patients with advanced ROS1/TRK fusion-positive solid tumors (TRIDENT-1 study)
Presenter: Alexander Drilon
Session: Poster Discussion – Developmental therapeutics
Resources:
Abstract